Rapid evaluation of PHD2 inhibitory activity of natural products based on capillary electrophoresis online stacking strategy

J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Apr 1:1236:124064. doi: 10.1016/j.jchromb.2024.124064. Epub 2024 Feb 28.

Abstract

Prolyl hydroxylase domain 2 (PHD2) is an important enzyme in the human body that perceives changes in oxygen concentration and regulates response in hypoxic environments. Evaluation of PHD2 inhibitory activity of natural products is crucial for drug development of hypoxia related diseases. At present, the detection of low concentration of α-ketoglutaric acid (the substrate of PHD2 enzymatic reaction) requires derivatization reactions or sample pretreatment, which undoubtedly increases the workload of PHD2 inhibitory activity evaluation. In this paper, a direct detection approach of α-ketoglutaric acid was established by using the online stacking strategy of capillary electrophoresis to evaluate the PHD2 inhibitory activity of natural products. Under optimized conditions, detection of a single sample can be achieved within 2 min. By calculation, the intraday precision RSD of the apparent electrophoretic mobility and peak areas of α-ketoglutaric acid are 0.92 % and 0.79 %, respectively, and the interday RSD were 1.27 % and 0.96 % respectively. The recoveries of the present approach were 97.9-105.2 %, and the LOQ and LOD were 2.0 μM and 5.0 μM, respectively. Furthermore, this approach was applied for the evaluation of inhibitory activity of PHD2 for 13 natural products, and PHD2 inhibitory activity of salvianolic acid A was firstly reported. The present work not only realizes evaluation of PHD2 inhibitory activity through direct detection of α-ketoglutaric acid, but also provides technical support for the discovery of potential drug molecules in hypoxia related diseases.

Keywords: Activity evaluation; Hypoxia; Natural products; Online stacking; Prolyl hydroxylase domain 2.

MeSH terms

  • Biological Products* / pharmacology
  • Electrophoresis, Capillary* / methods
  • Humans
  • Hypoxia-Inducible Factor-Proline Dioxygenases* / antagonists & inhibitors
  • Ketoglutaric Acids* / analysis

Substances

  • Biological Products
  • EGLN1 protein, human
  • Hypoxia-Inducible Factor-Proline Dioxygenases
  • Ketoglutaric Acids